OraSure Technologies (OSUR) Tops Q1 EPS by 2c

Go back to OraSure Technologies (OSUR) Tops Q1 EPS by 2c

OraSure Announces 2016 First Quarter Financial Results

May 4, 2016 4:00 PM EDT

BETHLEHEM, Pa., May 04, 2016 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced its consolidated financial results for the first quarter ended March 31, 2016.

Financial Highlights

Consolidated net revenues for the first quarter of 2016 were $29.1 million, a 7% increase from the first quarter of 2015.  Net domestic revenues from sales of the Companys OraQuick® rapid HCV test were $1.9 million for the first quarter of 2016, representing a 59% increase over the first quarter of 2015. Total HCV-related revenues, including exclusivity payments... More

OraSure Technologies to Present at the UBS 2016 Global Healthcare Conference

May 3, 2016 6:00 AM EDT

BETHLEHEM, Pa., May 03, 2016 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the UBS 2016 Global Healthcare Conference in New York.  The conference will be simultaneously webcast over the Internet.

Mr. Michels is scheduled to speak May 23, 2016, at approximately 10:30... More